ascendis pharma glp-1 receptor agonist weight management diabetes treatments Top Agonists Balance Loss Efficacy, Safety GLP−1 receptor agonists for the
Description
Diabetes (2004) 53(3):65462

For patients with diabetic kidney disease, the glucose-lowering effect of SGLT2is may be impaired

Elucidating the underlying cellular and molecular mechanisms could potentially usher in the development of new generations of incretin mimetics with enhanced efficacy and fewer adverse effects

Clinical implication The potential ocular complications associated with GLP-1 RAs need careful clinical consideration

The combination of adherent exercise and Lira treatment reduced abdominal obesity and may therefore reduce obesity risk more than the individual treatments [101]